If your premature baby developed necrotizing enterocolitis — or you lost them to it — after being fed Similac or Enfamil in the NICU, you’re probably asking three things at once: how much, do I qualify, and is it too late? Here are the honest, current answers. State juries have handed families more than $565 million in standing NEC verdicts, with a $3 billion total exposure estimate hanging over the manufacturers. But there is still no settlement — and the litigation had a rough summer: one of the early plaintiff wins was just reversed on appeal, and the first-ever federal trial, delayed for months, only opened this week. Here is exactly where the Enfamil NEC lawsuit and Similac lawsuit stand right now.
The 30-second version: No NEC baby formula settlement has been approved. Verdicts to date range from $60 million (reversed on appeal) up to $495 million (upheld). The first federal bellwether — Inman v. Mead Johnson — began opening statements on August 17, 2026, after being postponed four times. Eligibility generally means a premature infant fed cow’s-milk-based Similac or Enfamil who developed NEC.
No FDA recall issued No settlement or payout chart exists Not a class action — each case is individual
How Much Are NEC Settlements? (Estimated Payouts)
The most important thing to understand up front: there is no NEC formula settlement, and no per-child payout chart exists. Anyone offering a tidy “average Enfamil lawsuit settlement” or “Similac lawsuit settlement amount” is guessing. The only hard dollar figures in this necrotizing enterocolitis baby formula lawsuit litigation are individual jury verdicts from state-court trials, plus broad estimates analysts use to talk about eventual value. The table below separates what’s real from what’s projection — and reflects a major correction: one of the early “wins” families often cite has since been thrown out on appeal.
| Case or injury category | Reported amount or estimated range | Status / note |
|---|---|---|
| $495M verdict — Similac (Jul 2024) | $495 million ($95M compensatory + $400M punitive) | Upheld by a Missouri appeals court in 2026 |
| $70M verdict — Similac, four families (Apr 2026) | $70 million ($53M compensatory + $17M punitive) | Cook County, IL jury against Abbott; Abbott has said it will appeal |
| $60M verdict — Enfamil, infant death (Mar 2024) | $60 million | Reversed on appeal, June 2026 — sent back for a new trial |
| Defense verdict — Enfamil Premature 24 (Jul 2026) | $0 to plaintiff | St. Louis jury sided with Mead Johnson on causation |
| Death / wrongful death (illustrative estimate) | ~$500,000 to $2 million+ | Speculative estimate only — no settlement exists; not an offer or guarantee |
| Severe NEC (surgery, lasting complications) | ~$250,000 to $1 million+ | Speculative estimate only — not an offer or guarantee |
| Moderate NEC (no surgery) | ~$75,000 to $250,000 | Speculative estimate only — not an offer or guarantee |
Read the bottom three rows with real skepticism — because no settlement exists, there is no verified “per person” value. Even the jury verdicts above are unstable: one has already been erased on appeal, and Abbott has signaled it will challenge the $70 million Cook County result too. Standing plaintiff verdicts currently total roughly $565 million ($495M + $70M) — not the “$625 million-plus” figure you may see floating around, which still counts the reversed $60 million award. Financial analysts at Bloomberg Intelligence have pegged Abbott and Mead Johnson’s combined eventual exposure at around $3 billion, but that’s an outside projection, not money on the table. If you’ve followed how figures evolve in other mass torts, the pattern is similar to our Roundup lawsuit settlement amounts and AFFF lawsuit settlement amounts pages: headlines come from verdicts, but most claimants are eventually resolved through negotiated tiers that only appear after a global settlement — which hasn’t happened here.
What Compensation Actually Covers (Damages Categories)
Families often ask what a verdict or eventual settlement is actually paying for. In an NEC baby formula lawsuit, “damages” generally fall into a few buckets — and which ones apply depends heavily on whether your child survived, needed surgery, or died.
- Past and future medical bills — the NICU stay itself, any NEC-related surgery (including bowel resection or an ostomy), follow-up procedures like ostomy reversal, and ongoing gastrointestinal or nutritional care.
- Pain and suffering — physical pain endured by the child, and in many states, the emotional toll on parents who watched their baby go through it.
- Long-term care and life-care costs — for children who survive with short bowel syndrome, developmental delays, or other lasting complications, this can include therapy, specialized formula or nutrition support, and future medical monitoring.
- Lost future earning capacity — in cases with permanent cognitive or physical impairment, some claims include projected impact on the child’s future ability to work.
- Wrongful-death damages — a separate legal category covering funeral and burial costs, the loss of the child’s life, and the family’s grief (see the wrongful-death section below).
- Punitive damages — seen in the $495 million and $70 million verdicts, these are meant to punish the company for its conduct rather than compensate the family directly, and they’re often the part most likely to be reduced on appeal.
Quick Answers to the Top Questions
How much could I get?
No one can honestly promise a figure — there’s no settlement and no payout matrix. Verdicts have ranged from $60M (now reversed) to $495M, but those are outliers, not a guide to an average claim. See payouts.
Who qualifies?
Generally a premature infant fed cow’s-milk-based Similac or Enfamil who developed NEC, including cases ending in death. You’ll need medical records. Full criteria in eligibility.
Is there a settlement yet?
No. As of August 2026 there’s no approved global settlement. “Settlement amounts” you see online are jury verdicts and estimates, not guaranteed payouts.
Which formulas, specifically?
Cow’s-milk-based Similac (Abbott) and Enfamil (Mead Johnson/Reckitt) preterm formulas and human-milk fortifiers. Named products in this section.
Am I suing the hospital?
Usually no — these are product-liability claims against the manufacturers, not medical malpractice against your NICU doctors. See the distinction.
What’s the deadline?
It depends entirely on your state, and minors’ claims are often tolled until adulthood. There’s no single national deadline — see statute of limitations.
Am I Eligible? 60-Second Self-Check
This isn’t legal advice, and it doesn’t submit anywhere — it’s just a quick gut-check before you talk to an attorney. Check what applies to your situation:
Checked all four? You likely meet the basic threshold criteria attorneys look for first. The records requirement (box four) is usually the easiest place to start — most firms will help you request them once you sign on.
Who Qualifies for an NEC Lawsuit?
Eligibility in the preterm infant formula lawsuit litigation is fairly specific. Claims center on premature babies given a cow’s-milk-based formula or fortifier who then developed necrotizing enterocolitis. The four building blocks below are what attorneys check first.
| Requirement | Detail |
|---|---|
| Prematurity | Baby born premature — typically before about 37 weeks. The strongest cases involve infants born before 32 weeks or at very low birth weight (often under ~1,500 grams). |
| Cow’s-milk-based Similac or Enfamil | The infant was fed a bovine (cow’s-milk) formula or fortifier, frequently in the NICU. |
| NEC diagnosis | A documented NEC diagnosis, surgery for NEC, lasting complications, or a death attributed to NEC. A baby who recovered without surgery can still qualify — surgery isn’t a requirement, though it typically affects how a claim is valued. |
| Records | NICU and medical records connecting the three points above: proof of prematurity, evidence the cow’s-milk product was fed, and the NEC diagnosis or cause of death. |
How do I know if the NICU gave my baby Similac or Enfamil? This is one of the most common questions we hear, and the answer is almost always sitting in the hospital’s own paperwork — specifically the feeding orders and nursing flow sheets in the NICU chart, not the discharge summary. If you don’t have a copy, you (or your attorney) can request the full NICU record from medical records/health information management at the hospital; federal law (HIPAA) gives parents/guardians the right to a copy of a minor child’s records.
If a hospital’s own feeding decisions are part of your story, your situation may also touch on birth-injury law — see our guide to birth injury attorneys and proving medical negligence.
Which Specific Similac & Enfamil Products Are Named?
Yes — both brands are named in active cases, and it’s not just the generic brand name. Court filings identify specific product lines fed to the plaintiffs’ children:
| Manufacturer | Product | Typical use |
|---|---|---|
| Abbott | Similac Special Care Similac Special Care 24 | Standard preterm-infant formula, NICU feeding |
| Abbott | Similac Human Milk Fortifier | Added to breast milk to boost calories/nutrients for very low birth weight infants |
| Mead Johnson / Reckitt | Enfamil Premature 24 Enfamil Premature 24 Cal | Standard preterm-infant formula, NICU feeding |
| Mead Johnson / Reckitt | Enfamil Human Milk Fortifier | Added to breast milk to boost calories/nutrients for very low birth weight infants |
The common thread is that these are bovine (cow’s-milk)-based products fed to fragile preterm babies — including the fortifiers mixed into breast milk, not just standalone formula. The lawsuits don’t claim the products were contaminated or manufactured defectively; they’re failure-to-warn claims, alleging Abbott and Mead Johnson didn’t adequately warn families and doctors that cow’s-milk-based nutrition carries a higher NEC risk for premature infants than human milk. A bovine-based fortifier lawsuit follows the same basic eligibility criteria as a formula claim — what matters is the cow’s-milk source, not whether it came in a can or a fortifier packet. That distinction sits at the heart of how these product liability claims are argued. Importantly, there has been no recall of any of these products — regulators still treat preterm formula as a necessary option when human milk isn’t available.
Hospital or Formula Maker — Who Am I Actually Suing?
This trips up a lot of parents, so it’s worth being precise. The NEC baby formula MDL and the related state-court cases are product liability lawsuits against the manufacturers — Abbott and Mead Johnson/Reckitt — not medical malpractice claims against your NICU doctors or the hospital.
Why this matters: the “learned intermediary doctrine”
Formula makers generally argue their duty to warn runs to the treating physicians, not directly to parents — a legal principle called the learned intermediary doctrine. This isn’t a technicality: it’s exactly what an Illinois appeals court ruled in June 2026 when it reversed the $60 million Enfamil verdict, finding the trial judge wrongly told jurors Mead Johnson owed a duty to warn the mother personally. That case is now headed for a retrial.
In rare cases, a hospital or physician’s own conduct — a delayed diagnosis, a feeding-order error, or ignoring early warning signs of NEC — can support a separate medical malpractice claim, but that’s a different legal track with its own, often shorter, filing deadlines and a higher bar of proof around the standard of medical care. Most families pursuing an Enfamil NEC lawsuit or Similac lawsuit are not suing their hospital at all — but if you believe your NICU team made a specific error, it’s worth having a birth injury attorney review that separately from a product-liability claim against the manufacturer.
The Science: Why Formula Is Linked to NEC
Necrotizing enterocolitis is a serious, sometimes fatal intestinal disease that strikes premature babies, causing portions of the bowel to become inflamed and die. It’s one of the most dangerous conditions in the NICU.
Research consistently shows human milk is protective and formula-fed preemies develop NEC at higher rates. In a 2024 randomized clinical trial published in JAMA, NEC occurred in about 9% of extremely preterm infants fed preterm formula versus roughly 4% fed donor human milk — close to double the rate. A separate 2024 Cochrane systematic review of donor human milk versus formula reported a similar protective pattern. This evidence base is what plaintiffs rely on.
But honesty requires the other half of the picture, because it’s exactly what the manufacturers argue — and what federal judges have weighed. In an October 2024 consensus statement, the FDA, CDC, and NIH concluded that prematurity is the primary risk factor for NEC, that human milk significantly reduces — but doesn’t eliminate — the risk, and that there’s no conclusive proof that preterm formula itself causes NEC. In other words, the science strongly links the absence of human milk to higher NEC risk, while stopping short of declaring formula a proven cause. That nuance is the central scientific battleground of this Abbott Laboratories NEC litigation.
NEC Lawsuit Verdicts So Far (2024–2026)
Every NEC dollar figure actually awarded has come from a state court, not the federal MDL — and the scoreboard shifted significantly this summer. Here’s the honest rundown:
- $60 million (March 2024, Illinois) — now reversed. A jury originally found against Mead Johnson over the death of a premature infant fed Enfamil. In June 2026, the Illinois Fifth District Court of Appeal reversed the verdict, ruling the trial judge misapplied the learned intermediary doctrine (see the hospital vs. manufacturer section) and that improper evidence about Mead Johnson’s revenue may have swayed the jury. The case has been sent back for a new trial.
- $495 million (July 2024, Missouri) — upheld. A jury awarded $95 million compensatory and $400 million punitive against Abbott over Similac. A Missouri appeals court upheld the full verdict in 2026, rejecting Abbott’s key defenses.
- $70 million (April 2026, Illinois) — Abbott appealing. A Cook County jury awarded four families a combined $53 million compensatory and $17 million punitive against Abbott over Similac Special Care 24. All four children survived but required surgery. Abbott has said it will appeal.
- Defense verdict (July 2026, Missouri) — plaintiff loss. Just weeks after the $60 million reversal, a St. Louis jury sided with Mead Johnson in a separate case involving Enfamil Premature 24, finding the plaintiff hadn’t proven specific causation.
Not every twist has favored the manufacturers, though: a separate 2024 Missouri defense verdict for Abbott and Mead Johnson was later thrown out by a judge after finding misconduct by defense counsel, and that case was ordered to be retried.
The federal picture has been tougher for plaintiffs overall. The first three federal Similac bellwethers were dismissed on summary judgment before ever reaching a jury — including Mar v. Abbott, whose dismissal the Seventh Circuit Court of Appeals affirmed in late July 2026, on narrow warning-causation grounds specific to that family’s hospital (it had no donor milk available, so a different label warning wouldn’t have changed the outcome). That ruling doesn’t disturb the $495 million verdict or the broader science. Crucially, in the fourth case — Inman — the judge did not throw out the plaintiffs’ causation experts; she let that testimony stand, which is why Inman became the first federal case to actually reach a jury. That’s a real, sobering split, and it’s the kind of litigation risk every preterm infant formula lawsuit claimant should understand before filing.
Where the Litigation Stands: MDL 3026 & the August 2026 Trial
The federal cases are consolidated as MDL No. 3026, In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, before U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois. As of August 2026 there are roughly 825 cases pending in the MDL, with hundreds more in state courts.
Live update: the first federal trial is happening right now
Inman v. Mead Johnson & Company — the first federal bellwether ever to reach a jury, involving the death of infant Daniel Windley after Enfamil feeding in the NICU — was originally slated for July 6, 2026. That date came and went with no proceedings; it was the trial’s fourth postponement. Jury selection finally began August 13, 2026, and opening statements started Monday, August 17, 2026. As of this update, the trial is underway in Chicago and no verdict has been reached. This is the most consequential pending event in the federal litigation: a plaintiff verdict would put real pressure on both companies to discuss a global resolution; a defense verdict would suggest even a bellwether that survives summary judgment can’t convert into a jury win.
A second wave of Similac-only bellwethers — Cresap v. Abbott, Kelton v. Abbott, and a third case — was scheduled for August, November 2026, and February 2027, with Abbott as the sole defendant in each. Given how many times the Inman date slipped, treat any specific date you see for these Similac-only trials as provisional until it’s confirmed closer to the day; we’ll update this page once a firm status is public.
There is still no global settlement. The $3 billion Bloomberg Intelligence exposure estimate remains an outside projection, not money on the table. For context on how a large pharmaceutical mass tort tends to move from verdicts toward resolution, our overview of Depo-Provera lawsuit settlements tracks a comparable arc.
How to File an NEC Claim
Filing is mostly about evidence. The practical steps:
- Gather the records. You’ll need NICU and medical records establishing prematurity, showing the cow’s-milk Similac or Enfamil product was fed, and documenting the NEC diagnosis (or cause of death). Obtaining them is usually the first thing an attorney helps with.
- Consult a licensed attorney. An experienced mass-tort or product-liability lawyer among the growing pool of preterm infant formula lawsuit lawyers can assess whether your facts fit the litigation and where your case should be filed.
- Understand MDL vs. state court. Despite the name, this is not a class action — each family has an individual claim. Federal cases are coordinated in MDL 3026 for pretrial purposes, while many plaintiffs have chosen state courts, where the biggest verdicts have come from. (See our explainer on how to file a class action lawsuit — and how an MDL differs from one.)
NEC Lawsuit Deadline: Statute of Limitations by State
This is the question where a wrong answer can cost a family their case, so be careful with anything online — including this article — that implies a single nationwide deadline. There isn’t one.
| Item | What to know |
|---|---|
| General statute of limitations | Varies by state — commonly around two years from the injury or its discovery, but the range is wide. Don’t rely on a single number. |
| NEC lawsuit statute of limitations tolling for minors | In many states a child’s own claim is “tolled” (paused) until they reach the age of majority — typically 18, though it runs to 19 in a few states — which can extend the window well into the child’s teenage or young-adult years. This is why families sometimes ask, “can I still file if my child is now a toddler or a teenager?” The answer in most states is yes, though the exact rule is state-specific and not automatic. |
| Wrongful-death claims | A separate, often shorter deadline that typically runs from the date of death rather than the date of injury. |
| Aug 17, 2026 | Opening statements in the first federal bellwether trial, Inman v. Mead Johnson — ongoing, no verdict yet. |
Because tolling for minors and wrongful-death deadlines can pull in opposite directions, the only safe move is to have a licensed attorney check your specific state’s deadline as soon as possible. Waiting to “see how the trial goes” can quietly run out a clock you didn’t know was ticking.
Wrongful-Death NEC Claims
For families who lost a baby to NEC, this is the hardest section, and we’re sorry you’re reading it. A wrongful-death claim is legally distinct from an injury claim. Generally, the right to file belongs to a defined group of survivors — most often a parent or the estate’s representative — and recoverable damages can include medical and funeral costs, loss of the child’s life, and the family’s grief, depending on the state (see the full breakdown in damages categories above).
The most important practical point is the deadline: wrongful-death claims usually run from the date of death and can be shorter than the injury deadline, so they deserve prompt attention. Our guide to wrongful death attorneys in 2026 walks through who can file and how these claims are valued, and a birth injury attorney can help if a hospital’s feeding decisions are also part of what happened.
What Recovery Can Look Like
The scenario below is an illustrative composite, not an actual case, meant to show what a “surgery and lasting complications” claim often involves — not to speak for any specific family.
A baby born at 27 weeks develops NEC in the third week of life after being fed a cow’s-milk-based fortifier in the NICU. Emergency surgery removes a damaged section of bowel, and the baby lives with a temporary ostomy bag for several months while the intestine heals. A second surgery later reverses the ostomy. The child survives, but the family is left with a stretch of NICU and surgical bills, months of specialized follow-up care, and — depending on how much bowel was affected — the possibility of long-term digestive issues. This is the kind of outcome the “severe NEC, surgery, lasting complications” damages category is built around.
Frequently Asked Questions
How much are NEC baby formula settlements?
There are no settlements yet, so there’s no settlement amount. The only currently standing verdicts are $495 million and $70 million (the latter on appeal) — outliers tied to severe, specific cases, not a guide to an average payout. A third verdict, $60 million, was reversed on appeal in June 2026.
What specific Enfamil and Similac products are named in the lawsuits?
Cases identify Similac Special Care and Similac Special Care 24, Similac Human Milk Fortifier, Enfamil Premature 24 (Enfamil Premature 24 Cal), and Enfamil Human Milk Fortifier — all cow’s-milk-based products used in NICUs.
Who qualifies for an NEC lawsuit?
Generally, a premature infant fed cow’s-milk-based Similac or Enfamil (often in the NICU) who then developed NEC, including cases that ended in the child’s death. Medical records establishing all three points are required.
Is there an NEC settlement yet?
No. As of August 2026 there’s no approved global settlement in the federal litigation, and no per-child payout chart exists.
Can I file an NEC lawsuit if my child is now a toddler or teenager?
Often, yes. Many states pause (“toll”) a child’s own statute of limitations until they reach the age of majority, meaning the filing window may still be open years after the injury. The exact rule depends on your state — have an attorney confirm it rather than assuming the door is closed.
Can you sue for NEC if the baby recovered without surgery?
Generally yes — a documented NEC diagnosis is what matters, not whether surgery was required. Claims without surgery typically fall into a lower damages range since there’s less permanent injury, but they can still be viable if the medical records are solid.
Does it cost anything upfront to hire an NEC lawsuit lawyer?
Most mass-tort and product-liability attorneys handle these cases on a contingency-fee basis — meaning they only get paid a percentage if you win or settle, with no upfront legal fees. Ask any firm you’re considering to explain their fee percentage and how case costs are handled before you sign anything.
Has the FDA recalled Similac or Enfamil due to NEC risk?
No. There has been no FDA recall of Similac or Enfamil tied to NEC risk. Regulators continue to treat preterm formula as a necessary option in NICUs when human milk isn’t available, even as the litigation over warning labels continues.
Am I suing the hospital or the formula company?
In almost all of these cases, you’d be suing the manufacturer — Abbott or Mead Johnson/Reckitt — under a product-liability, failure-to-warn theory, not the hospital or your NICU doctors under a medical malpractice theory. See the full explanation above.
What’s the deadline to file in my state?
It varies by state. Minors’ claims are often paused until the child grows up, and wrongful-death deadlines differ. There’s no universal deadline — have a licensed attorney confirm yours.
Where does the litigation stand right now?
About 825 cases are pending in federal MDL 3026 before Judge Pallmeyer, plus hundreds in state courts. The first federal trial, Inman v. Mead Johnson, opened with jury selection on August 13, 2026 and opening statements on August 17, 2026, after four postponements. No verdict has been reached yet, and no global settlement exists.
This article is for informational and educational purposes only and is not legal or medical advice. There is no approved NEC formula settlement; jury verdicts are individual, may be appealed, reversed, or reduced, and do not guarantee any payout. Federal bellwether cases have had mixed outcomes, and litigation results vary. Statutes of limitations differ by state. Consult a licensed attorney about your specific situation before taking action.
Sources
- FDA, CDC & NIH — Consensus statement on premature infants and necrotizing enterocolitis (Oct 2024)
- JAMA (2024) — Randomized trial: donor human milk vs. preterm formula in extremely preterm infants
- AboutLawsuits.com — Enfamil NEC lawsuit cleared for MDL trial; original July 2026 date set
- Law.com — Jury selection Aug. 13, opening arguments Aug. 17 in the Inman bellwether
- Law.com — Mead Johnson wins defense verdict; Illinois appeals court reversal of the $60M verdict
- AboutLawsuits.com — Second-wave Similac bellwether trials scheduled (Cresap, Kelton, and a third case)
- Business Wire — First federal Enfamil NEC bellwether trial scheduled
Last updated: — to be updated when the Inman v. Mead Johnson trial reaches a verdict and as the Similac second-wave bellwether dates are confirmed.

Daniel Hayes is the founder and sole researcher at AdvoraHQ. He covers U.S. personal finance, insurance, and consumer law — working directly from IRS publications, federal and state statutes, court opinions, and SEC filings rather than secondary summaries. His focus is the gap between what readers think they know and what the source documents actually say. Daniel is not a licensed attorney, CPA, or financial advisor; his articles are educational and not personalized advice. Reach him at Daniel.Hayes@advorahq.com.
